BackGeneFerm Biotechnology , Ltd. Overview

GeneFerm Biotechnology , Ltd. Total Liabilities

GeneFerm Biotechnology , Ltd.'s total liabilities is $440M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$435.15M
↓ 4.80% YoYΔ $-21.93M vs prior year quarter

Peer trimmed avg / median

Loading

GeneFerm Biotechnology , Ltd. Total Liabilities History

Loading

GeneFerm Biotechnology , Ltd. vs. peers: Total Liabilities Comparison

Loading

GeneFerm Biotechnology , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GeneFerm Biotechnology , Ltd. (1796.TWO) FAQ

GeneFerm Biotechnology , Ltd. (1796.TWO) currently reports a total liabilities of $440M as of September 2026. That compares with $460M in the prior-year period — down 4.8% year over year. Use the charts on this page to explore GeneFerm Biotechnology , Ltd.'s total liabilities history and peer comparisons.

GeneFerm Biotechnology , Ltd.'s total liabilities decreased from $460M to $440M — a 4.8% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GeneFerm Biotechnology , Ltd. reported $440M in total liabilities as of September 2026. That compares with $460M in the prior-year period — down 4.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $440M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneFerm Biotechnology , Ltd., and consider following 1796.TWO for alerts when major investors trade the stock.